Yi‐Zarn Wang

761 total citations
47 papers, 567 citations indexed

About

Yi‐Zarn Wang is a scholar working on Epidemiology, Oncology and Neurology. According to data from OpenAlex, Yi‐Zarn Wang has authored 47 papers receiving a total of 567 indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Epidemiology, 30 papers in Oncology and 29 papers in Neurology. Recurrent topics in Yi‐Zarn Wang's work include Neuroendocrine Tumor Research Advances (31 papers), Neuroblastoma Research and Treatments (28 papers) and Lung Cancer Research Studies (18 papers). Yi‐Zarn Wang is often cited by papers focused on Neuroendocrine Tumor Research Advances (31 papers), Neuroblastoma Research and Treatments (28 papers) and Lung Cancer Research Studies (18 papers). Yi‐Zarn Wang collaborates with scholars based in United States and Australia. Yi‐Zarn Wang's co-authors include Eugene A. Woltering, J. Philip Boudreaux, Robert A. Ramirez, Aman Chauhan, Lowell Anthony, Ramcharan Thiagarajan, A. Wright, Gregg Mamikunian, Catherine T. Anthony and Melissa Stevens and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Gastroenterology.

In The Last Decade

Yi‐Zarn Wang

42 papers receiving 551 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yi‐Zarn Wang United States 16 387 364 278 66 65 47 567
Al M. Elsayed United States 10 383 1.0× 391 1.1× 247 0.9× 220 3.3× 97 1.5× 13 697
Lone Bording Astrup Denmark 8 254 0.7× 153 0.4× 123 0.4× 115 1.7× 20 0.3× 15 450
Amanda N. Graff‐Baker United States 10 105 0.3× 250 0.7× 67 0.2× 162 2.5× 72 1.1× 21 490
Maria Rinzivillo Italy 20 990 2.6× 961 2.6× 600 2.2× 77 1.2× 49 0.8× 66 1.1k
Barbro Eriksson Sweden 11 308 0.8× 293 0.8× 244 0.9× 54 0.8× 32 0.5× 19 395
Vikram Chaudhari India 14 143 0.4× 360 1.0× 74 0.3× 265 4.0× 205 3.2× 82 514
Todd M. Luckasevic United States 7 97 0.3× 168 0.5× 46 0.2× 94 1.4× 60 0.9× 8 302
F. Kümmerle Germany 9 192 0.5× 257 0.7× 83 0.3× 199 3.0× 71 1.1× 98 419
Oskar Kornasiewicz Poland 12 208 0.5× 184 0.5× 84 0.3× 215 3.3× 68 1.0× 37 554
Wouter T. Zandee Netherlands 15 678 1.8× 626 1.7× 512 1.8× 104 1.6× 36 0.6× 38 836

Countries citing papers authored by Yi‐Zarn Wang

Since Specialization
Citations

This map shows the geographic impact of Yi‐Zarn Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi‐Zarn Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi‐Zarn Wang more than expected).

Fields of papers citing papers by Yi‐Zarn Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yi‐Zarn Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi‐Zarn Wang. The network helps show where Yi‐Zarn Wang may publish in the future.

Co-authorship network of co-authors of Yi‐Zarn Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Yi‐Zarn Wang. A scholar is included among the top collaborators of Yi‐Zarn Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yi‐Zarn Wang. Yi‐Zarn Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Woltering, Eugene A., et al.. (2017). Aggressive Surgical Approach to the Management of Neuroendocrine Tumors: A Report of 1,000 Surgical Cytoreductions by a Single Institution. Journal of the American College of Surgeons. 224(4). 434–447. 58 indexed citations
2.
Woltering, Eugene A., A. Wright, Melissa Stevens, et al.. (2016). Development of effective prophylaxis against intraoperative carcinoid crisis. Journal of Clinical Anesthesia. 32. 189–193. 45 indexed citations
3.
Wang, Yi‐Zarn, et al.. (2016). Obturator Canal Lymph Node Metastasis from Rectal Carcinoid Tumors: Total Mesorectal Excision May Be Insufficient. Journal of Gastrointestinal Surgery. 20(6). 1247–1252. 4 indexed citations
4.
Wang, Yi‐Zarn, et al.. (2016). Does receptor status impact survival of patients with mid-gut neuroendocrine tumors?. Journal of Clinical Oncology. 34(4_suppl). 227–227. 1 indexed citations
5.
Woltering, Eugene A., et al.. (2015). Elevated Plasma Pancreastatin, but Not Chromogranin A, Predicts Survival in Neuroendocrine Tumors of the Duodenum. Journal of the American College of Surgeons. 222(4). 534–542. 11 indexed citations
6.
Wang, Yi‐Zarn, et al.. (2014). Reappraisal of lymphatic mapping for midgut neuroendocrine patients undergoing cytoreductive surgery. Surgery. 156(6). 1498–1503. 15 indexed citations
7.
Wang, Yi‐Zarn, et al.. (2014). A 60-Year-Old Man With Chronic Cough and Green Sputum. Gastroenterology. 147(3). 575–576. 1 indexed citations
8.
Wang, Yi‐Zarn, et al.. (2014). A Single Institution's Experience with Surgical Cytoreduction of Stage IV, Well-Differentiated, Small Bowel Neuroendocrine Tumors. Journal of the American College of Surgeons. 218(4). 837–844. 37 indexed citations
9.
Wang, Yi‐Zarn, et al.. (2014). Surgical Treatment Options for Rectal Carcinoid Cancer: Local versus Low Radical Excision. The American Surgeon. 80(1). 31–35. 7 indexed citations
10.
Wang, Yi‐Zarn, et al.. (2012). Cervical and Upper Mediastinal Lymph Node Metastasis from Gastrointestinal and Pancreatic Neuroendocrine Tumors: True Incidence and Management. Journal of the American College of Surgeons. 214(6). 1017–1022. 4 indexed citations
11.
Lyons, John, et al.. (2011). Do Primary Neuroendocrine Tumors and Metastasis Have the Same Characteristics?. Journal of Surgical Research. 174(2). 200–206. 5 indexed citations
12.
Anthony, Catherine T., Jessica L. Thomson, John Lyons, et al.. (2011). A Study of Pipeline Drugs in Neuroendocrine Tumors. Journal of Gastrointestinal Cancer. 43(2). 296–304. 2 indexed citations
13.
Lyons, John, Catherine T. Anthony, Jessica L. Thomson, et al.. (2009). The Role of VEGF Pathways in Human Physiologic and Pathologic Angiogenesis. Journal of Surgical Research. 159(1). 517–527. 19 indexed citations
14.
Wang, Yi‐Zarn, et al.. (2009). Percutaneous localisation of pulmonary nodules prior to video-assisted thoracoscopic surgery using methylene blue and TC-99. European Journal of Cardio-Thoracic Surgery. 37(1). 237–238. 33 indexed citations
15.
Wang, Yi‐Zarn. (2009). Staged Second-Look Laparoscopy to Evaluate Ischemic Bowel. JSLS Journal of the Society of Laparoscopic & Robotic Surgeons. 13(4). 560–563. 4 indexed citations
16.
Wang, Yi‐Zarn, Gregory D. Espenan, Thomas R. Maloney, et al.. (2007). A Phase I/II Trial of 125I Methylene Blue for One-Stage Sentinel Lymph Node Biopsy. Annals of Surgery. 245(2). 290–296. 16 indexed citations
17.
Wang, Yi‐Zarn, et al.. (2003). Effect of Human Angiostatin® Protein on Human Angiogenesis in vitro. Angiogenesis. 6(3). 233–240. 8 indexed citations
18.
Hornick, Conrad A., et al.. (2002). Effect of human recombinant Endostatin® protein on human angiogenesis. Angiogenesis. 5(1-2). 111–118. 20 indexed citations
19.
Hunt, John P., Gregory S. Cherr, Curtis Hunter, et al.. (2000). Accuracy of Administrative Data in Trauma: Splenic Injuries as an Example. The Journal of Trauma: Injury, Infection, and Critical Care. 49(4). 679–688. 32 indexed citations
20.
Meyers, Michael O., et al.. (2000). Suramin Analogs Inhibit Human Angiogenesis in Vitro. Journal of Surgical Research. 91(2). 130–134. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Al M. Elsayed Breakdown of academic impact, for papers by Lone Bording Astrup Breakdown of academic impact, for papers by Amanda N. Graff‐Baker Breakdown of academic impact, for papers by Maria Rinzivillo Breakdown of academic impact, for papers by Barbro Eriksson Breakdown of academic impact, for papers by Vikram Chaudhari Breakdown of academic impact, for papers by Todd M. Luckasevic Breakdown of academic impact, for papers by F. Kümmerle Breakdown of academic impact, for papers by Oskar Kornasiewicz Breakdown of academic impact, for papers by Wouter T. Zandee
Rankless by CCL
2026